Dreyling, M. Et Al. 2019. Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Florida, United States Of America).

Dreyling, M., Panayiotidis, P., Follows, G. A., Mollica, L., Nagler, A., ÖZCAN, M., ... Santoro, A.(2019). Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma . 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America

Dreyling, Martin Et Al. "Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma," 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 2019

Dreyling, Martin Et Al. "Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America, 2019

Dreyling, M. Et Al. (2019) . "Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America.

@conferencepaper{conferencepaper, author={Martin Dreyling Et Al. }, title={Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma}, congress name={61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Florida}, country={United States Of America}, year={2019}}